This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
G Amori , RH Lenox (1989). Do volunteer subjects bias clinical trials? Journal of Clinical Psychopharmacology 9, 321–327.
J Angst , A Gamma , F Benazzi , B Silverstein , VA Ajdacic-Gross , D Eich , W Rössler (2006). Atypical depressive syndromes in varying definitions. European Archives of Psychiatry and Clinical Neuroscience 257, 44–54.
J Angst , A Gamma , R Sellaro , H Zhang , K Merikangas (2002). Toward validation of atypical depression in the community: results of the Zurich cohort study. Journal of Affective Disorders 72, 125–138.
H Anisman , AV Ravindran , J Griffiths , Z Merali (1999). Endocrine and cytokine correlates of major depression and dysthymia with and without atypical features. Molecular Psychiatry 4, 182–188.
F Benazzi (1999). Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study. Psychiatry Research 86, 259–264.
F Benazzi (2002). Psychomotor changes in melancholic and atypical depression: unipolar and bipolar-II subtypes. Psychiatry Research 112, 211–220.
RJ Bielski , RB Lydiard (1997). Therapeutic trial participants: where do we find them and what does it cost? Psychopharmacology Bulletin 33, 75–78.
WA Brown , MF Johnson , MG Chen (1992). Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Research 41, 203–214.
PK Corey-Lisle , R Nash , P Stang (2004). Swindle R. Response, partial response, and nonresponse in primary care treatment of depression. Archives of Internal Medicine 164, 1197–1204.
JR Davidson , RD Miller , CD Turnbull , JL Sullivan (1982). Atypical depression. Archives of General Psychiatry 39, 527–534.
M Fava , AJ Rush , MH Trivedi , AA Nierenberg , ME Thase , HA Sackeim , FM Quitkin , S Wisniewski , PW Lavori , JF Rosenbaum , DJ Kupfer (2003). Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatric Clinics of North America 26, 457–494.
M Hamilton (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278–296.
JM Himmelhoch , ME Thase , AG Mallinger , P Houck (1991). Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry 148, 910–916.
E Horwath , J Johnson , MM Weissman , CD Hornig (1992). The validity of major depression with atypical features based on a community study. Journal of Affective Disorders 26, 117–126.
PR Joyce , RT Mulder , SE Luty , PF Sullivan , JM McKenzie , RM Abbott , IF Stevens (2002). Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Australian and New Zealand Journal of Psychiatry 36, 384–391.
KS Kendler , LJ Eaves , EE Walters , MC Neale , AC Heath , RC Kessler (1996). The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Archives of General Psychiatry 53, 391–399.
AY Khan , J Carrithers , SH Preskorn , R Lear , SR Wisniewski , AJ Rush , D Stegman , C Kelley , K Kreiner , AA Nierenberg , M Fava (2006). Clinical and demographic factors associated with DSM-IV melancholic depression. Annals of Clinical Psychiatry 18, 91–98.
MR Liebowitz , FM Quitkin , JW Stewart , PJ McGrath , WM Harrison , JS Markowitz , JG Rabkin , E Tricamo , DM Goetz , DF Klein (1988). Antidepressant specificity in atypical depression. Archives of General Psychiatry 45, 129–137.
BS Linn , MW Linn , L Gurel (1968). Cumulative Illness Rating Scale. Journal of the American Geriatric Society 16, 622–626.
J Lonnqvist , S Sihvo , E Syvalahti , O Kiviruusu (1994). Moclobemide and fluoxetine in atypical depression: a double-blind trial. Journal of Affective Disorders 32, 169–177.
LS Matza , DA Revicki , JR Davidson , JW Stewart (2003). Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Archives of General Psychiatry 60, 817–826.
PJ McGrath , JW Stewart , MN Janal , E Petkova , FM Quitkin , DF Klein (2000). A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. American Journal of Psychiatry 157, 344–350.
PJ McGrath , JW Stewart , FM Quitkin , Y Chen , JE Alpert , AA Nierenberg , M Fava , J Cheng , E Petkova (2006). Predictors of relapse in a prospective study of fluoxetine treatment of major depression. American Journal of Psychiatry 163, 1542–1548.
MD Miller , CF Paradis , PR Houck , S Mazumdar , JA Stack , AH Rifai , B Mulsant , CF Reynolds III (1992). Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Research 41, 237–248.
JS Novick , JW Stewart , SR Wisniewski , IA Cook , R Manev , AA Nierenberg , JF Rosenbaum , K Shores-Wilson , GK Balasubramani , MM Biggs , S Zisook , AJ Rush ; STAR*D investigators (2005). Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. Journal of Clinical Psychiatry 66, 1002–1011.
AC Pande , M Birkett , S Fechner-Bates , RF Haskett , JF Greden (1996). Fluoxetine versus phenelzine in atypical depression. Biological Psychiatry 40, 1017–1020.
G Parker , I Blignault (1983). A comparative study of neurotic depression in symptomatic volunteers. Australia and New Zealand Journal of Psychiatry 17, 74–81.
G Parker , K Roy , P Mitchell , K Wilhelm , G Malhi , D Hadzi-Pavlovic (2002). Atypical depression: a reappraisal. American Journal of Psychiatry 159, 1470–1479.
ES Paykel , JA Hollyman , P Freeling , P Sedgwick (1988). Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. Journal of Affective Disorders 14, 83–95.
G Perugi , HS Akiskal , L Lattanzi , D Cecconi , C Mastrocinque , A Patronelli , S Vignoli , E Bemi (1998). The high prevalence of ‘soft’ bipolar (II) features in atypical depression. Comprehensive Psychiatry 39, 63–71.
MA Posternak , M Zimmerman (2002). Partial validation of the atypical features subtype of major depressive disorder. Archives of General Psychiatry 59, 70–76.
FM Quitkin , PJ McGrath , JW Stewart , W Harrison , E Tricamo , SG Wager , K Ocepek-Welikson , E Nunes , JG Rabkin , DF Klein (1990). Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Archives of General Psychiatry 47, 935–941.
JG Rabkin , JW Stewart , FM Quitkin , PJ McGrath , WM Harrison , DF Klein (1996). Should atypical depression be included in DSM-IV? In: TA Widiger , AJ Frances , HA Pincus , R Ross , MB First , WW Davis (Eds.), APA DSM-IV Source Book (pp. 239–260). Washington, DC: American Psychiatric Association.
MH Rapaport , T Frevert , S Babior , S Seymour , S Zisook , J Kelsoe , LL Judd (1996). A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders. Journal of Clinical Psychopharmacology 16, 242–246.
E Robins , SB Guze (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126, 983–987.
AJ Rush , TJ Carmody , HM Ibrahim , MH Trivedi , MM Biggs , K Shores-Wilson , ML Crismon , MG Toprac , TM Kashner (2006). Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatric Services 57, 829–837.
AJ Rush , M Fava , SR Wisniewski , PW Lavori , MH Trivedi , HA Sackeim , ME Thase , AA Nierenberg , FM Quitkin , TM Kashner , : Sequenced Treatment Alternatives to Relieve Depression (STAR*D) (2004). Rationale and design. Controlled Clinical Trials 25, 118–141.
AJ Rush , DE Giles , MA Schlesser , CL Fulton , J Weissenburger , C Burns (1986). The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Research 18, 65–87.
AJ Rush , MH Trivedi , HM Ibrahim , TJ Carmody , B Arnow , DN Klein , JC Markowitz , PT Ninan , S Kornstein , R Manber , (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573–585.
D Smith , C Dempster , J Glanville , N Freemantle , I Anderson (2002). Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. British Journal of Psychiatry 180, 396–404.
J Søgaard , R Lane , P Latimer , K Behnke , PE Christiansen , B Nielsen , AV Ravindran , RT Reesal , DP Goodwin (1999). A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression. Journal of Psychopharmacology 13, 406–414.
JW Stewart , PJ McGrath , FM Quitkin , DF Klein (2007). Atypical depression: Current status and relevance to melancholia. Acta Psychiatrica Scandanavia 115 (Suppl. 433), 58–71.
JW Stewart , PJ McGrath , FM Quitkin , DF Klein (in press). DSM-IV depression with atypical features: is it valid? Neuropsychopharmacology.
JW Stewart , FM Quitkin , MR Liebowitz , PJ McGrath , WM Harrison , DF Klein (1983). Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness. Archives of General Psychiatry 40, 202–207.
JW Stewart , FM Quitkin , PJ McGrath , J Amsterdam , M Fava , J Fawcett , F Reimherr , J Rosenbaum , C Beasley , P Roback (1998). Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Archives of General Psychiatry 55, 334–343.
P Stratta , F Bolino , M Cupillari , M Casacchia (1991). A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression. International Clinical Psychopharmacology 6, 193–196.
PF Sullivan , RC Kessler , KS Kendler (1998). Latent class analysis of lifetime depressive symptoms in the National Comorbidity Survey. American Journal of Psychiatry 155, 1398–1406.
J Tedlow , M Fava , L Uebelacker , AA Nierenberg , JE Alpert , J Rosenbaum (1998). Outcome definitions and predictors in depression. Psychotherapy & Psychosomatics 67, 266–270.
ME Thase , AR Entsuah , RL Rudolph (2001). Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. British Journal of Psychiatry 178, 234–241.
ME Thase , CG Last , M Hersen , AS Bellack , JM Himmelhoch (1984). Symptomatic volunteers in depression research: a closer look. Psychiatry Research 11, 25–33.
MH Trivedi , AJ Rush , HM Ibrahim , TJ Carmody , MM Biggs , T Suppes , ML Crismon , K Shores-Wilson , MG Toprac , EB Dennehy , B Witte , TM Kashner (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 34, 73–82.
MH Trivedi , AJ Rush , SR Wisniewski , AA Nierenberg , D Warden , L Ritz , G Norquist , RH Howland , B Lebowitz , PJ McGrath , ; STAR*D Study Team (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 163, 28–40.
SR Wisniewski , AJ Rush , GK Balasubramani , MH Trivedi , AA Nierenberg (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice 12, 71–79.
M Zimmerman , I Chelminski , MA Posternak (2005). Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. American Journal of Psychiatry 162, 1370–1372.
M Zimmerman , JI Mattia (2001 a). A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry 58, 787–794.
M Zimmerman , JI Mattia (2001 b). The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Comprehensive Psychiatry 42, 175–189.